RSPO4 protein and mRNA expression was decreased after BRAF knockout when compared to wild-type (Figure 6A–D) in our panel of metastatic and non-metastatic human thyroid cancer cell lines (THJ-16T, 8505C and TPC-1). This evidence concerns the gene BRAF and thyroid cancer.